Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent Gadoquatrane at ECR 2026
At European Congress of Radiology (ECR) 2026, Bayer highlighted new developments in MRI technologies and contrast agents aimed at improving diagnostic efficiency and patient care.





































